Venetoclax and Homoharringtonine‐Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T‐Cell Precursor Acute Lymphoblastic LeukemiaXiang Zhang, Wenjuan Yu, Liping Mao et al.|MedComm|2025Cited by 1